vs
HELIX ENERGY SOLUTIONS GROUP INC（HLX）与Ultragenyx Pharmaceutical Inc.（RARE）财务数据对比。点击上方公司名可切换其他公司
HELIX ENERGY SOLUTIONS GROUP INC的季度营收约是Ultragenyx Pharmaceutical Inc.的1.4倍（$287.9M vs $207.3M），HELIX ENERGY SOLUTIONS GROUP INC净利率更高（-4.7% vs -62.0%，领先57.4%），Ultragenyx Pharmaceutical Inc.同比增速更快（25.9% vs -13.8%），HELIX ENERGY SOLUTIONS GROUP INC自由现金流更多（$59.0M vs $-100.8M），过去两年Ultragenyx Pharmaceutical Inc.的营收复合增速更高（38.0% vs -11.2%）
Helix Energy Solutions是总部位于美国得克萨斯州休斯顿的油气服务企业，2006年前名为Cal Dive International。该企业是全球离岸油气服务供应商，为新建及在产油气田提供油井干预作业以及遥控潜水器作业服务。
Ultragenyx Pharmaceutical Inc.是一家总部位于美国的生物制药企业，专注于研发罕见病和超罕见遗传病的创新治疗方案，这类疾病目前大多无获批疗法，存在大量未被满足的临床需求。公司覆盖生物制剂、小分子药物、基因疗法、反义寡核苷酸及mRNA等多种药物技术平台，研发管线涵盖骨骼、内分泌、代谢、肌肉及中枢神经系统疾病领域。
HLX vs RARE — 直观对比
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $287.9M | $207.3M |
| 净利润 | $-13.4M | $-128.6M |
| 毛利率 | 3.1% | — |
| 营业利润率 | — | -54.7% |
| 净利率 | -4.7% | -62.0% |
| 营收同比 | -13.8% | 25.9% |
| 净利润同比 | -536.4% | 3.5% |
| 每股收益（稀释后） | $-0.09 | $-1.28 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
| Q1 26 | $287.9M | — | ||
| Q4 25 | $334.2M | $207.3M | ||
| Q3 25 | $377.0M | $159.9M | ||
| Q2 25 | $302.3M | $166.5M | ||
| Q1 25 | $278.1M | $139.3M | ||
| Q4 24 | $355.1M | $164.6M | ||
| Q3 24 | $342.4M | $139.5M | ||
| Q2 24 | $364.8M | $147.0M |
| Q1 26 | $-13.4M | — | ||
| Q4 25 | $8.3M | $-128.6M | ||
| Q3 25 | $22.1M | $-180.4M | ||
| Q2 25 | $-2.6M | $-115.0M | ||
| Q1 25 | $3.1M | $-151.1M | ||
| Q4 24 | $20.1M | $-133.2M | ||
| Q3 24 | $29.5M | $-133.5M | ||
| Q2 24 | $32.3M | $-131.6M |
| Q1 26 | 3.1% | — | ||
| Q4 25 | 15.2% | — | ||
| Q3 25 | 17.5% | — | ||
| Q2 25 | 4.9% | — | ||
| Q1 25 | 9.9% | — | ||
| Q4 24 | 16.6% | — | ||
| Q3 24 | 19.2% | — | ||
| Q2 24 | 20.7% | — |
| Q1 26 | — | — | ||
| Q4 25 | 3.7% | -54.7% | ||
| Q3 25 | 12.7% | -106.9% | ||
| Q2 25 | -1.0% | -64.8% | ||
| Q1 25 | 2.9% | -102.6% | ||
| Q4 24 | 8.7% | -74.3% | ||
| Q3 24 | 13.0% | -94.6% | ||
| Q2 24 | 14.6% | -79.1% |
| Q1 26 | -4.7% | — | ||
| Q4 25 | 2.5% | -62.0% | ||
| Q3 25 | 5.9% | -112.8% | ||
| Q2 25 | -0.9% | -69.0% | ||
| Q1 25 | 1.1% | -108.5% | ||
| Q4 24 | 5.7% | -80.9% | ||
| Q3 24 | 8.6% | -95.7% | ||
| Q2 24 | 8.9% | -89.5% |
| Q1 26 | $-0.09 | — | ||
| Q4 25 | $0.06 | $-1.28 | ||
| Q3 25 | $0.15 | $-1.81 | ||
| Q2 25 | $-0.02 | $-1.17 | ||
| Q1 25 | $0.02 | $-1.57 | ||
| Q4 24 | $0.13 | $-1.34 | ||
| Q3 24 | $0.19 | $-1.40 | ||
| Q2 24 | $0.21 | $-1.52 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $501.3M | $421.0M |
| 总债务越低越好 | $303.8M | — |
| 股东权益账面价值 | $1.6B | $-80.0M |
| 总资产 | $2.6B | $1.5B |
| 负债/权益比越低杠杆越低 | 0.20× | — |
8季度趋势，按日历期对齐
| Q1 26 | $501.3M | — | ||
| Q4 25 | $445.2M | $421.0M | ||
| Q3 25 | $338.0M | $202.5M | ||
| Q2 25 | $319.7M | $176.3M | ||
| Q1 25 | $370.0M | $127.1M | ||
| Q4 24 | $368.0M | $174.0M | ||
| Q3 24 | $324.1M | $150.6M | ||
| Q2 24 | $275.1M | $480.7M |
| Q1 26 | $303.8M | — | ||
| Q4 25 | $308.0M | — | ||
| Q3 25 | $307.5M | — | ||
| Q2 25 | $311.6M | — | ||
| Q1 25 | $311.1M | — | ||
| Q4 24 | $315.2M | — | ||
| Q3 24 | $314.7M | — | ||
| Q2 24 | $318.6M | — |
| Q1 26 | $1.6B | — | ||
| Q4 25 | $1.6B | $-80.0M | ||
| Q3 25 | $1.6B | $9.2M | ||
| Q2 25 | $1.6B | $151.3M | ||
| Q1 25 | $1.5B | $144.2M | ||
| Q4 24 | $1.5B | $255.0M | ||
| Q3 24 | $1.6B | $346.8M | ||
| Q2 24 | $1.5B | $432.4M |
| Q1 26 | $2.6B | — | ||
| Q4 25 | $2.6B | $1.5B | ||
| Q3 25 | $2.6B | $1.2B | ||
| Q2 25 | $2.7B | $1.3B | ||
| Q1 25 | $2.6B | $1.3B | ||
| Q4 24 | $2.6B | $1.5B | ||
| Q3 24 | $2.7B | $1.5B | ||
| Q2 24 | $2.6B | $1.6B |
| Q1 26 | 0.20× | — | ||
| Q4 25 | 0.19× | — | ||
| Q3 25 | 0.20× | — | ||
| Q2 25 | 0.20× | — | ||
| Q1 25 | 0.20× | — | ||
| Q4 24 | 0.21× | — | ||
| Q3 24 | 0.20× | — | ||
| Q2 24 | 0.21× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $61.8M | $-99.8M |
| 自由现金流经营现金流 - 资本支出 | $59.0M | $-100.8M |
| 自由现金流率自由现金流/营收 | 20.5% | -48.6% |
| 资本支出强度资本支出/营收 | 1.0% | 0.5% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $167.4M | $-472.0M |
8季度趋势，按日历期对齐
| Q1 26 | $61.8M | — | ||
| Q4 25 | $113.2M | $-99.8M | ||
| Q3 25 | $24.3M | $-91.4M | ||
| Q2 25 | $-17.1M | $-108.3M | ||
| Q1 25 | $16.4M | $-166.5M | ||
| Q4 24 | $78.0M | $-79.3M | ||
| Q3 24 | $55.7M | $-67.0M | ||
| Q2 24 | $-12.2M | $-77.0M |
| Q1 26 | $59.0M | — | ||
| Q4 25 | $107.5M | $-100.8M | ||
| Q3 25 | $22.6M | $-92.7M | ||
| Q2 25 | $-21.6M | $-110.7M | ||
| Q1 25 | $12.0M | $-167.8M | ||
| Q4 24 | $65.5M | $-79.5M | ||
| Q3 24 | $52.5M | $-68.6M | ||
| Q2 24 | $-16.2M | $-79.0M |
| Q1 26 | 20.5% | — | ||
| Q4 25 | 32.2% | -48.6% | ||
| Q3 25 | 6.0% | -58.0% | ||
| Q2 25 | -7.1% | -66.5% | ||
| Q1 25 | 4.3% | -120.5% | ||
| Q4 24 | 18.4% | -48.3% | ||
| Q3 24 | 15.3% | -49.2% | ||
| Q2 24 | -4.4% | -53.7% |
| Q1 26 | 1.0% | — | ||
| Q4 25 | 1.7% | 0.5% | ||
| Q3 25 | 0.4% | 0.8% | ||
| Q2 25 | 1.5% | 1.5% | ||
| Q1 25 | 1.6% | 1.0% | ||
| Q4 24 | 3.5% | 0.1% | ||
| Q3 24 | 0.9% | 1.2% | ||
| Q2 24 | 1.1% | 1.4% |
| Q1 26 | — | — | ||
| Q4 25 | 13.68× | — | ||
| Q3 25 | 1.10× | — | ||
| Q2 25 | — | — | ||
| Q1 25 | 5.35× | — | ||
| Q4 24 | 3.88× | — | ||
| Q3 24 | 1.89× | — | ||
| Q2 24 | -0.38× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
HLX
暂无分部数据
RARE
| Royalty | $105.6M | 51% |
| Products | $101.7M | 49% |
